We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies content piece image
Whitepaper

Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy, and combination immunotherapies increase cost of treatment and heighten the risk for toxicity-related adverse events.
Whitepaper

Accelerating Cancer Immune Cell Therapies

As we have gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life.
Challenging Host Cell Protein Assays for Improved Risk Mitigation content piece image
Whitepaper

Challenging Host Cell Protein Assays for Improved Risk Mitigation

At high levels, host cell proteins (HCPs) can cause immunogenic responses and reduced efficacy of biologics, so it is imperative to have an effective, robust HCP assay to detect them and mitigate these effects.
Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies content piece image
Whitepaper

Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy.
Advancing the Development of Therapeutics Against Infectious Diseases content piece image
Whitepaper

Advancing the Development of Therapeutics Against Infectious Diseases

Novel and emerging infectious diseases can be a serious threat to human health and the global economy, as exhibited by the current SARS-CoV-2 outbreak. To mitigate these threats, it is necessary to initiate comprehensive containment strategies such as
Calibration Certificates From Accredited Providers content piece image
Whitepaper

Calibration Certificates From Accredited Providers

Download this whitepaper to learn about the advantages of calibration certificates, concepts of accredited calibration and traceability of test equipment.
Reliable Results from Cell-Based Bioassays content piece image
Whitepaper

Reliable Results from Cell-Based Bioassays

While common laboratory plastics are generally regarded as inert by researchers, some commonly used products such as pipette tips and sample tubes have been reported to leach chemical compounds including oleamide, erucamide and DiHEMDA.
Profiling Host Responses in COVID-19 Infections content piece image
Whitepaper

Profiling Host Responses in COVID-19 Infections

Download this whitepaper to discover how next-generation ELISA technology can accelerate biomarker discovery and provide in-depth analysis of COVID-19 host cytokine levels.
Quantify and Characterize Host Cell Protein With Confidence content piece image
Whitepaper

Quantify and Characterize Host Cell Protein With Confidence

Download this whitepaper to learn more about how dilutional linearity enhances reliability, undetected HCP can be minimized as well as consistently low variation ensures reproducible data.
Insight - Research Advancements with Proteomics Technology content piece image
Whitepaper

Insight - Research Advancements with Proteomics Technology

Proteins are one of the most vital parts of living organisms with many functions, using the latest proteomics methods it is now possible to understand how protein changes in our body influence health and disease, particularly during ageing.
Advertisement